在接受血造干细胞移植手术的儿童和青少年中患有沙尔科佩尼亚
Cláudia G Lewandowski1, Adriana Garofolo2, Heitor P Leite1
1Discipline of Pediatric Nutrition, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
Hematology, transfusion and cell therapy
|March 14, 2024
概括
萨尔科佩尼亚 (肌肉质量和力量减少) 影响11%的儿科患者在血造细胞干细胞移植 (HSCT) 之前. 在入院时,较高的炎症和皮症与HSCT后更大的手握强度损失相关.
科学领域:
- 儿科血液学 儿科血液学
- 移植免疫学 移植免疫学
- 肌肉生理学 肌肉生理学
背景情况:
- 由肌肉质量,强度和功能的下降来定义的sarcopenia与不良结果有关.
- 儿童血型造血干细胞移植 (HSCT) 患者中肉类的患病率和炎症对肌肉强度丧失的影响尚不清楚.
- 这项研究调查了小儿HSCT接受者的萨尔科佩尼亚患病率和相关因素.
研究的目的:
- 估计接受HSCT的儿童和青少年入院时的肉类的患病率.
- 在这个人群中识别与肉类相关的临床因素.
- 确定住院期间全身炎症反应对肌肉力量损失的影响.
主要方法:
- 一项前性研究,涉及80名接受HSCT的儿科患者 (6-18岁).
- 在入院时评估了sarcopenia的患病率 (力量和骨肌肉质量的损失).
- 医院住院期间测量了握力损失,潜在的解释变量包括年龄,肉病状况,营养状况和全身炎症标志物 (血清C反应蛋白,白蛋白,费里丁).
主要成果:
- 11%的患者在入院时出现了肉症.
- 女性性别,入院时的肉类,以及血清C-反应蛋白水平升高与从入院到HSCT后14天的手握力损失有显著关联.
- 具体来说,入院时的肉类 (β = 0.70,p = 0.018) 和C反应蛋白度 (β = -0.10,p = 0.001) 与手握强度降低相关.
结论:
- 入院时的肉类和系统性炎症的程度与儿科HSCT患者的手握强度降低有关.
- 这些发现强调了评估儿科HSCT接受者的肌肉健康和炎症的重要性.
- 为了巩固这些关联,需要进一步研究标准化的肉症诊断标准.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
329
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
329
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


